FAKTOR OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 13:21:10 27/06/2024 BST | ||
| 6.04 EUR | -1.79% |
|
| Current month | +9.82% | ||
| 1 month | +7.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 6.04 | -1.79% |
| 26/06/24 | 6.15 | -7.80% |
| 25/06/24 | 6.67 | +3.25% |
| 24/06/24 | 6.46 | +8.39% |
| 21/06/24 | 5.96 | +0.34% |
Delayed Quote Deutsche Boerse AG
Last update June 27, 2024 at 01:21 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PH4AMG |
| ISIN | DE000PH4AMG7 |
| Date issued | 27/02/2020 |
| Strike | 312.8 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.98 € |
|---|---|
| Lowest since issue | 2.22 € |
| Spread | 0.05 € |
| Spread % | 0.82% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.16%
- Stock Market
- Certificates
- Certificat
